Chinese clinical practice guideline on the management of Crohn′s disease (2023, Guangzhou)
陈旻湖 1吴开春 2周静 古敏怡
扫码查看
点击上方二维码区域，可以放大扫码查看
作者信息
1. 中山大学附属第一医院消化内科，广州 510080
2. 空军军医大学西京医院消化病医院，西安 710032
折叠
摘要
克罗恩病（CD）病情复杂，涉及多个学科，规范化诊疗对提高CD的疗效及改善预后非常重要。近年来我国在CD领域的基础及临床研究取得丰硕成果，加上新的诊疗理念、新的治疗药物不断应用于临床，使更新CD诊疗共识意见、为广大临床工作者提供基于最新循证依据的诊治指南成为必要。本指南是由中华医学会消化病学分会炎症性肠病学组结合国外最新共识、国内研究成果和实际情况，在2018年版炎症性肠病诊断和治疗共识意见基础上进行修订。本指南的制定旨在反映当前CD临床诊治的最新理念及研究成果，为CD的临床诊治提供规范化指导意见。 Crohn′s disease (CD) is a complex condition spanning multiple disciplines. Standardized diagnostics and treatment are paramount for enhancing the medical efficacy and improving the prognosis of CD. In recent years, substantial progress has been achieved in both basic and clinical research on CD. The integration of novel diagnostic and therapeutic paradigms, new treatment modalities, have necessitated the update of consensus on CD management, offering imperative, evidence-based guidelines for health providers. This guideline, collaboratively developed by the Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, incorporates the latest international consensus, domestic research findings, and practical considerations, as an update based on the 2018 Chinese consensus on diagnosis and treatment in inflammatory bowel disease. The formulation of this guideline aims to reflect the latest concepts and research findings in the clinical diagnosis and treatment of CD, providing standardized guidance for the clinical management of CD.
Abstract
Crohn′s disease (CD) is a complex condition spanning multiple disciplines. Standardized diagnostics and treatment are paramount for enhancing the medical efficacy and improving the prognosis of CD. In recent years, substantial progress has been achieved in both basic and clinical research on CD. The integration of novel diagnostic and therapeutic paradigms, new treatment modalities, have necessitated the update of consensus on CD management, offering imperative, evidence-based guidelines for health providers. This guideline, collaboratively developed by the Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, incorporates the latest international consensus, domestic research findings, and practical considerations, as an update based on the 2018 Chinese consensus on diagnosis and treatment in inflammatory bowel disease. The formulation of this guideline aims to reflect the latest concepts and research findings in the clinical diagnosis and treatment of CD, providing standardized guidance for the clinical management of CD.
万方数据